Zobrazeno 1 - 10
of 848
pro vyhledávání: '"Vaishali, S."'
Autor:
Tuffy, Kevin M., Ahani, Bahar, Domachowske, Joseph B., Furuno, Kenji, Ji, Hong, Madhi, Shabir A., Mankad, Vaishali S., Hamrén, Ulrika Wählby, Villafana, Tonya, Wang, Yingyi, Kelly, Elizabeth J., Wilkins, Deidre
Publikováno v:
In Vaccine 24 October 2024 42(24)
Autor:
Kumbhar, Maruti B., Patil, Vinod V., Chandak, Vaishali S., Gunjakar, Jayavant L., Kulal, Prakash M.
Publikováno v:
In Journal of Alloys and Compounds 5 January 2025 1010
Publikováno v:
In Materials Chemistry and Physics 1 January 2025 329
Publikováno v:
In Journal of the Indian Chemical Society March 2024 101(3)
Autor:
Vaishali S. Mankad, Amanda Leach, Yue Chang, Ulrika Wählby Hamrén, Alexandre Kiazand, Robert J. Kubiak, Therese Takas, Tonya Villafana, Manish Shroff
Publikováno v:
Pathogens, Vol 13, Iss 6, p 503 (2024)
Background: Nirsevimab is approved in the US for the prevention of respiratory syncytial virus (RSV) lower respiratory tract disease in neonates and infants during their first RSV season and in children aged ≤24 months who remain vulnerable to seve
Externí odkaz:
https://doaj.org/article/86743bdbdfea4b6889ccb3ced6d076df
Autor:
Bahar Ahani, Kevin M. Tuffy, Anastasia A. Aksyuk, Deidre Wilkins, Michael E. Abram, Ron Dagan, Joseph B. Domachowske, Johnathan D. Guest, Hong Ji, Anna Kushnir, Amanda Leach, Shabir A. Madhi, Vaishali S. Mankad, Eric A. F. Simões, Benjamin Sparklin, Scott D. Speer, Ann Marie Stanley, David E. Tabor, Ulrika Wählby Hamrén, Elizabeth J. Kelly, Tonya Villafana
Publikováno v:
Nature Communications, Vol 15, Iss 1, Pp 1-2 (2024)
Externí odkaz:
https://doaj.org/article/62972434e0cc4edfafbaf60c3024f8ec
Publikováno v:
MGM Journal of Medical Sciences. Apr-Jun2024, Vol. 11 Issue 2, p254-261. 8p.
Autor:
Bahar Ahani, Kevin M. Tuffy, Anastasia A. Aksyuk, Deidre Wilkins, Michael E. Abram, Ron Dagan, Joseph B. Domachowske, Johnathan D. Guest, Hong Ji, Anna Kushnir, Amanda Leach, Shabir A. Madhi, Vaishali S. Mankad, Eric A. F. Simões, Benjamin Sparklin, Scott D. Speer, Ann Marie Stanley, David E. Tabor, Ulrika Wählby Hamrén, Elizabeth J. Kelly, Tonya Villafana
Publikováno v:
Nature Communications, Vol 14, Iss 1, Pp 1-10 (2023)
Abstract Nirsevimab is a monoclonal antibody that binds to the respiratory syncytial virus (RSV) fusion protein. During the Phase 2b (NCT02878330) and MELODY (NCT03979313) clinical trials, infants received one dose of nirsevimab or placebo before the
Externí odkaz:
https://doaj.org/article/fb9efa8bfa3c458ebbb25e11a772eeb6
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Deshpande, Shailesh V., Deshpande, Vaishali S., Kohli, Kuldeep Raj, Tamoli, Sanjay, Sakapal, Shashikant S.
Publikováno v:
In Journal of Ayurveda and Integrative Medicine September-October 2023 14(5)